［1］Stoffers HE，Rinkens PE，Kester AD，et al.The prevalence of asymptomatic and unrecognized peripheral arterial occlusive dis⁃ease.Int J Epidemiol，1996，25：282⁃290.

［2］Meijer WT，Hoes AW，Rutgers D，et al.Peripheral arterial disease in the elderly；the Rtterdam Study.Arterioscler Throm Vasc Biol，1998，18：185⁃192.

［3］　Aquino R，Johnnides C，Makaroun M，et al.Natural history of claudication：Long⁃term serial follow～up study of 1244 claudicants.JVasc Surg，2001，34：962⁃967.

［4］The ICAIGroup.Long～term mortality and its predictors in patientswith critical leg ischemia.Euro JVasc Endovasc Surg，1997，14：91⁃95.

［5］CAPRIE Steering Committee.Arandomized，blinded trial of clopidogrel versus aspirin in patiens at risk of ischaemic events.Lan⁃cet，1996，348：1329⁃1339.

［6］Leng GC，Lee AJ，Fowkes FG，et al.Incidence，natural history and cardiovascular events in sympytomatic and asymptomatic pe⁃ripheral arterial disease in the general population.Int JEpidemiol，1996，25：1172⁃1181.

［7］Ingolfsson IO，Sigurdson G，Sigvaldason H，et al.A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968⁃1986：a strong relationship to smoking and serum cholesterol⁃the Reykjavik study.J Clin Epidemiol，1994，47：1237⁃1243.

［8］Cheng SW，TingAC.Lipoprotein（a）level andmortality in patientswith critical lower limb ischaemia.Eur J Vasc Endovasc Surg，2001，22（2）：124⁃129.

［9］Sobel M，Verhaeghe R.Antithrombotic therapy for peripheral artery occlusive disease：American College of Chest Physicians Evi⁃dence Based Clinical Practice Guidelines（8th Edition）.Chest，2008，133（6Suppl）：8155⁃8435.

［10］Hoshino J，Ubara Y，Hara S，etal.Quality of life improvement and long term effects of peripheral blood mononuclear cell trans⁃plantation for severe arteriosclerosis obliterans in diabetic patients on dialysis.Circ J，2007，71（8）：1193⁃1198.

［11］van Weel V，van Tongeren RB，van Hinsbergh VW，etal.Vascular growth in ischemic limbs：a review ofmechanisms and possi⁃ble therapeutic stimulation.Ann Vasc Surg，2008，22（4）：582⁃597.

［12］Dagher NN，Modrall JG.Pharmacotherapy before and after revasculari⁃zation：anticoagulation，antiplateletagents，andstatins.Semin Vasc Surg，2007，20（1）：10⁃14.